• LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon

© 2015 - 2019 Ranomics Incorporated 

Drug Discovery:

Drug Target Validation

Prioritize and identify genetic variants as potential drug targets using our VERG platform

 

Ranomics' streamlined enables the characterization of thousands of genetic variants at once using a diverse set of biological readouts including: 

  • cellular growth

  • post-translational modifications

  • synthetic reporters 

 

Our analyses can be conducted across multiple cell lines to assess whether any genetic variant contributes to disease etiology and can serve as an effective therapeutic target. 

Accelerate cell-based studies with Ranomics and identify high-quality drug targets faster.

Get in touch
Let us show you how Ranomics can enable your R&D